Fig. 1 · Structure
Documents & Downloads
Monocalcium glycerophosphate
Intestinal Alkaline Phosphatase F3 Inhibitor
Monocalcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3, demonstrating anti-cavity properties. This compound serves as a vital source of calcium and phosphorus in total parenteral nutrition solutions, aiding in the prevention of mineralization and bone development related to intravenous nutrition. Additionally, it supports the integrity of the intestinal epithelium, making it valuable for various research applications in nutrition and gastrointestinal health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 27214-00-2 |
| Applications | Intestinal Alkaline Phosphatase F3 Inhibitor |
| Formula | C3H7CaO6P |
| Molecular Weight | 210.14 |
| SMILES | O=P([O-])([O-])OCC(O)CO.[Ca+2] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.